Header
Sir Ganga Ram Hospital, New Delhi
Bone Cancer: Symptoms, Stages and Treatment.
Medically Reviewed byDr. Aditya Sarin, MD, DrNB
Cancer Care · Sir Ganga Ram Hospital, New Delhi

Bone Cancer —
A Complete Overview.

Everything you need to know about bone cancer — from symptoms and staging to treatment options and life after diagnosis — explained clearly by Dr. Aditya Sarin.

Medical Disclaimer

This page is for informational purposes only and does not constitute medical advice, diagnosis or treatment. Every case of bone cancer is different. Please consult Dr Aditya Sarin or a qualified oncologist for evaluation, diagnosis and a treatment plan specific to your condition.

4
Main types of primary bone cancer
Young
Osteosarcoma skews younger, often teens
80%
Overall 5-year survival rate
Early
Detection changes outcomes

Bone pain that worsens at night, or doesn't improve with rest, deserves evaluation. Schedule an evaluation with Dr. Aditya Sarin today.

Section 01

What is Bone Cancer?

Bone cancer starts in the bone itself, where cells begin growing and dividing abnormally. It's important to draw a distinction here. Most cancer found in bone didn't actually start there. It's far more common for cancer to spread to bone from somewhere else, such as the breast, prostate, or lung. That's called metastatic or secondary bone cancer, and it's treated very differently from cancer that genuinely originates in the bone.

This page focuses on primary bone cancer — cancer that starts in the bone tissue itself. It's rare, making up less than 1% of all cancers, but it disproportionately affects children, teenagers, and young adults, which makes early recognition especially important.

Section 02

Types of Bone Cancer

Primary bone cancer is not a single disease. The specific type strongly influences who it affects, how it behaves, and how it's treated. Dr. Aditya Sarin evaluates each case individually to confirm the precise diagnosis before deciding on treatment.

Most Common Overall

Osteosarcoma

The most common type of primary bone cancer, and the most common in children and teenagers. Usually develops in the long bones of the arms and legs.

Most Common in Adults

Chondrosarcoma

Starts in cartilage cells. Typically grows more slowly than osteosarcoma and usually appears after age 40.

2nd Most Common (Children)

Ewing Sarcoma

Can grow and spread quickly, most often affecting the pelvis, chest wall, and long bones.

Rare · Specialised

Chordoma

A rare, slow-growing cancer that develops along the spine or at the base of the skull, requiring highly specialised surgical expertise.

Section 03

Symptoms of Bone Cancer

Bone pain is the most common early symptom, and it has a particular pattern worth knowing: it often gets worse at night and doesn't improve with rest, unlike most everyday aches and strains.

Bone pain that worsens at night or with activity
Swelling or a lump near a bone or joint
A bone that fractures with unusually minor trauma
Reduced range of motion near a joint
Fatigue
Unexplained weight loss
A limp, if the cancer affects a leg bone

Note: Growing pains and sports injuries are far more common than bone cancer, especially in children and teens. Still, pain that persists, worsens, or wakes someone up at night deserves proper evaluation.

Section 04

Causes & Risk Factors

The exact cause of most bone cancer isn't known, but a few factors are clearly linked to higher risk.

Age & Growth

Osteosarcoma occurs most often during the rapid bone growth of adolescence.

Paget's Disease of Bone

Causes abnormal bone growth and remodelling, raising the risk of osteosarcoma, particularly in older adults.

Prior Radiation Therapy

Radiation treatment for an earlier cancer, especially at a young age, increases risk years later.

Genetic Conditions

Li-Fraumeni syndrome and hereditary retinoblastoma significantly raise the risk of osteosarcoma.

Having a risk factor doesn't mean someone will develop bone cancer, and most people diagnosed have no identifiable risk factor beyond age.

Section 05

Bone Cancer Screening & Early Detection

There's no routine population-wide screening test for bone cancer. Early detection depends on recognising persistent bone pain or swelling and following through with proper imaging rather than assuming it's a strain or growing pain.

X-ray

Often the first imaging test, and frequently how a bone abnormality is first noticed.

MRI or CT Scan

Detailed imaging to assess the size of the tumour and whether it has spread beyond the bone.

Bone Biopsy

A tissue sample confirms the diagnosis, ideally performed at a centre experienced in bone sarcoma.

Chest CT

Since bone sarcomas can spread to the lungs, chest imaging is a standard part of the initial workup.

Persistent bone pain that doesn't fit the pattern of a typical strain, especially pain that wakes someone up at night or comes with swelling, deserves an X-ray rather than a wait-and-see approach.

Section 06

Staging of Bone Cancer

Staging describes how far the cancer has spread and directly shapes the treatment approach. Bone cancer staging combines tumour grade, how aggressive the cells look under a microscope, with tumour size and whether it has spread beyond the bone. This staging guidance is current as of 2026.

Stage
What it means
Stage I
Low-grade tumour, confined to the bone.
Stage II
High-grade tumour, still confined to the bone.
Stage III
Multiple tumours present within the same bone.
Stage IV
Cancer has spread to distant sites, most often the lungs or other bones.
Tumour grade matters enormously in bone cancer. A low-grade tumour and a high-grade tumour of similar size can have very different outlooks, which is why grading is built directly into the staging system.

Source: American Cancer Society, Bone Cancer Stages.

Section 07

Survival Rates by Type

Survival statistics are population averages. They describe outcomes across large groups of patients and don't predict what will happen to any individual patient.

Osteosarcoma outcomes in India

Measure
Value
5-year overall survival, non-metastatic extremity osteosarcoma (tertiary Indian centre, 100 patients)
65.5%
5-year survival with neoadjuvant chemotherapy before surgery
80%
5-year survival with upfront surgery, no neoadjuvant chemotherapy
39.5%
5-year survival, good tumour response to chemotherapy (over 90% necrosis)
93.2%

Source: Factors Affecting Prognosis and Survival in Extremity Osteosarcoma. The gap between neoadjuvant and upfront surgery outcomes in this study is striking, and underscores how much the specific treatment protocol followed shapes long-term survival.

Section 08

Treatment Options for Bone Cancer

Treatment depends on the specific type, grade, and stage. Bone cancer is treated by a multidisciplinary team, and Dr. Aditya Sarin coordinates a comprehensive, personalised treatment plan for every patient.

Limb-Salvage Surgery

Removes the tumour while preserving the limb, often using a metal implant or bone graft. The preferred approach whenever oncologically safe.

Amputation

Sometimes still necessary when a tumour is too large or too involved with nerves and blood vessels for limb-salvage surgery to be safe.

Chemotherapy

A cornerstone of treatment for osteosarcoma and Ewing sarcoma, typically given both before and after surgery.

Radiation Therapy

Chondrosarcoma responds poorly to radiation, but it plays a significant role in Ewing sarcoma, particularly when surgery isn't feasible.

Targeted Therapy

An option for select cases, including denosumab for giant cell tumour of bone, a related but distinct bone tumour.

Rehabilitation

Physiotherapy and, where needed, prosthetic fitting are a core part of recovery after limb-salvage surgery or amputation.

Section 09

Latest Advances in Bone Cancer Treatment

It's worth being honest here. Core treatment protocols for osteosarcoma have changed relatively little since the 1980s, when the addition of chemotherapy to surgery first transformed survival rates. Most current research effort is focused on the broader sarcoma family, and some of that progress is starting to open doors for bone sarcomas too.

1
FDA Full Approval · 2026 · Related Sarcoma Field

Engineered cell therapy reaches the sarcoma field

In 2024, the FDA granted accelerated approval to afamitresgene autoleucel, a T-cell receptor engineered cell therapy, for synovial sarcoma, a related soft tissue sarcoma. Full approval followed in 2026, with the treatment shrinking tumours in close to half of patients in the supporting trial, some with lasting responses. This is a soft tissue sarcoma approval rather than a primary bone sarcoma one, but it represents an important proof of concept for cell-based therapy across the sarcoma family, and similar approaches are now being studied in bone sarcomas.

Source: Memorial Sloan Kettering Cancer Center — FDA Grants Full Approval to Engineered Cell Therapy for Treating Rare Sarcoma.

2
Active Trials · Osteosarcoma

Active trials in osteosarcoma

Several current trials are testing whether adding targeted drugs such as cabozantinib to standard chemotherapy can improve outcomes in newly diagnosed and relapsed osteosarcoma, an area worth watching for patients with limited options after standard treatment stops working.

Whether a clinical trial or a newer treatment approach applies to a given patient depends on the exact diagnosis, prior treatment, and disease status, and should be discussed directly with a specialist familiar with current trial availability.
Section 10

Living with Bone Cancer

Bone cancer treatment, particularly surgery, affects mobility and daily function in ways that make coordinated rehabilitation an essential part of recovery, not an afterthought.

Physiotherapy & Mobility

Structured rehabilitation to rebuild strength and function after limb-salvage surgery or amputation.

Prosthetic & Reconstructive Support

Coordination with prosthetics and reconstructive specialists to support long-term mobility and independence.

Counselling & Support Groups

Emotional support and peer groups for patients and families, particularly valuable given how often this cancer affects children and young adults.

Section 11

Why Early Detection Matters

Bone pain in a growing teenager gets dismissed as growing pains more often than it should. It usually is nothing. But when it's not, catching it before it spreads to the lungs changes everything about the treatment path ahead.
— Dr. Aditya Sarin, Medical Oncologist
  • Localised osteosarcoma has a 5-year survival rate of 60 to 75%, compared with 15 to 30% once it has spread.
  • Bone pain that worsens at night, or doesn't improve with rest, is different from ordinary growing pains or a sports strain.
  • A fracture from unusually minor trauma should prompt imaging, not just a cast.
  • In an Indian tertiary care study, patients who received chemotherapy before surgery had roughly double the 5-year survival rate of those who went straight to surgery.
  • Persistent swelling near a bone or joint in a child or teenager deserves an X-ray, not just reassurance.
Section 12

Frequently Asked Questions about Bone Cancer

What is the first sign of bone cancer?

Bone pain that worsens at night or doesn't improve with rest is the most common early sign, sometimes along with swelling near the affected bone.

Is all bone cancer the same as cancer that has spread to the bone?

No, and this distinction matters a lot. Most cancer found in bone actually spread there from somewhere else, such as the breast, prostate, or lung. Primary bone cancer, which starts in the bone itself, is much rarer and treated differently.

Can bone cancer be cured?

Localised osteosarcoma has a 5-year survival rate of 60 to 75%, and many patients are cured. Outcomes are considerably lower once the cancer has spread, which is why early detection and getting the right treatment sequence matter so much.

Why does osteosarcoma mostly affect teenagers?

Osteosarcoma tends to develop during periods of rapid bone growth, which is thought to be part of why it's more common during the adolescent growth spurt than at other ages.

Is limb-salvage surgery always possible?

Not always. It depends on the tumour's size and how close it is to major nerves and blood vessels. When it's not oncologically safe, amputation remains necessary, though this is less common than it used to be thanks to advances in surgical technique.

Does chemotherapy really make that much difference for osteosarcoma?

Yes. Studies consistently show a large survival gap between patients who receive chemotherapy before surgery and those who go straight to surgery. It's one of the most important factors in the treatment protocol.

What is the best treatment approach for Bone Cancer in Delhi?

Effective bone cancer treatment in Delhi starts with an accurate biopsy and staging at a centre experienced in bone sarcoma, followed by a coordinated plan combining chemotherapy, surgery, and, where relevant, radiation. Dr. Aditya Sarin, ESMO board-certified and trained in precision oncology, offers this kind of multidisciplinary, personalised approach for bone cancer patients in Delhi.
Section 13 · Why Dr. Aditya Sarin

Why Trust Dr. Aditya Sarin for Bone Cancer Care?

ESMO Board Certified · Harvard Trained · Sir Ganga Ram Hospital, New Delhi

Experienced Bone Cancer Specialist

ESMO Board Certified oncologist with advanced training in precision oncology and cancer genomics from Harvard Medical School.

Coordinated Multidisciplinary Care

Treatment planned alongside orthopaedic oncology, radiation oncology, and rehabilitation specialists.

Comprehensive Support

Personalised treatment plans, rehabilitation coordination, emotional counselling, and end-to-end support.

Affordable & Accessible Care

High-quality oncology care with insurance assistance, flexible appointment options, and both in-person and remote consultations.

Mon – Sat (Morning) 10:00 AM – 12:00 PM
Mon – Sat (Evening) 4:00 PM – 6:00 PM
Sunday Closed

Early Detection Saves Lives

Don't dismiss persistent bone pain as just a strain, especially in a growing teenager. If you've noticed persistent bone pain, swelling, or simply want expert guidance following an unusual fracture, speak with Dr. Aditya Sarin — a trusted bone cancer specialist in New Delhi.

📅 Book Your Consultation